Clinical evolution and mortality of critically ill patients with SARS-CoV-2 pneumonia treated with remdesivir in an adult intensive care unit of Paraguay

Clinical evolution and mortality of critically ill patients with SARS-CoV-2 pneumonia treated with remdesivir in an adult intensive care unit of Paraguay

Abstract Background The health crisis due to Covid-19 led to the search for therapeutics that could improve the evolution of the disease. Remdesivir, an antiviral that interferes with viral replication, was one of the first to be used for the treatment of this pathology. Objective To determine clini...

Full description

Bibliographic Details
Main Authors: Jessica Figueredo, Lorena Fontclara Lopez, Belinda Figueredo Leguizamon, Margarita Samudio, Marcelo Pederzani, Federico Fretes Apelt, Patricia Añazco, Ricardo Caballero, Hugo Bianco
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Infectious Diseases
Subjects:
Remdesivir
Mortality
COVID-19
Intensive care
ARDS
Online Access:https://doi.org/10.1186/s12879-023-08917-2

Internet

https://doi.org/10.1186/s12879-023-08917-2

Similar Items